Top Wood­ford lieu­tenant hits ex­it in shake­up; Roche posts more im­pres­sive da­ta on he­mo­phil­ia A drug

Saku Sa­ha, one of Neil Wood­ford’s top lieu­tenants, has left the be­lea­guered UK com­pa­ny af­ter its con­tro­ver­sial clos­ing of the flag­ship fund fol­low­ing heavy loss­es, ac­cord­ing to a re­port in the Evening Stan­dard. The move, which was con­firmed, comes a decade af­ter Sa­ha be­gan work­ing with Wood­ford. He was one of three se­nior fund man­agers and had been in charge of ear­ly-stage biotech in­vest­ments. Ac­cord­ing to the re­port, his de­par­ture was han­dled am­i­ca­bly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.